Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 38 Lymphoma, Non-Hodgkin 32 Leukemia, Myeloid, Acute 26 Hodgkin Disease 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma 12 Myelodysplastic Syndromes 11 Leukemia, Lymphocytic, Chronic, B-Cell 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Neoplasms, Plasma Cell 6 Leukemia 6 Recurrence 3 Pancreatic Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Hematologic Neoplasms 3 Gliosarcoma 3 Glioblastoma 3 Warts 2 Sezary Syndrome 2 Neutropenia 2 Myeloproliferative Disorders 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Hairy Cell 2 Infections 2 Immunologic Deficiency Syndromes 2

Interventions

Doxorubicin 142 Ifosfamide 85 Radiotherapy 82 Cyclophosphamide 72 Gemcitabine 63 Filgrastim 54 pembrolizumab 43 pazopanib 40 Etoposide 39 Docetaxel 39 Vincristine 37 Trabectedin 37 Cisplatin 35 Nivolumab 32 Magnetic Resonance Spectroscopy 26 Irinotecan 26 Carboplatin 25 Temozolomide 23 Surgical Procedures, Operative 23 Radiation 22 Ipilimumab 22 Bevacizumab 20 Blood Specimen Collection 19 Granulocyte Colony-Stimulating Factor 18 Biopsy 18 eribulin 17 Sirolimus 17 Mesna 17 Melphalan 17 Dactinomycin 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × plerixafor × Clear all

NCT03240861 2023-11-01

NYESO SCT

Jonsson Comprehensive Cancer Center

Phase 1 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡